达英35治疗青春期功血的疗效观察
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
达英35治疗青春期功血的疗效观察
朱莉
【期刊名称】《检验医学与临床》
【年(卷),期】2017(014)0z2
【摘要】Objective To observe the efficacy of Diane-35 in treating adolescent DUB patients,as well as the adverse reactions and characteristics of Dane-35.Methods Selected 122 cases of adolescent DUB patients admitted to our hospital′s gynecology from January 2012 to November 2014.Divided those 122 cases into two groups:the observation group and the control group.Observation group were treated using Diane-35,while the control group using progynova + medroxyprogesterone sequential therapy.Results In the acute phase,Dane-35′s hemostas was better than the control group (P<0.01),showing significant difference.The time of vaginal bleeding becoming less and vaginal bleeding stop in observation group were both shorter than the control group,the differ-ence was significant (P<0.05).We compared the two groups of patients′menstrual recovery and found that the observation group was better than the control group (P<0.05),the difference was significant.We also compared the adverse reactions in two groups and found that the the incidence of adverse events in the observation group was 3.3% while the incidence in control group was 22. 95%,showing significant difference (P<0.05).Conclusion This study investigated the clinical efficacy of Diane-
35 in adolescent DUB.We draw Diane-35 hemostasis was better than progynova in the acute phase.Also Dane-35 was faster in acting than progyno-va,and its adverse reaction was lesser than progynova.The effect of Dane-35 on menstruation was more stable than progynova
+medroxyprogesterone sequential therapy.%目的通过临床试验,观察达英-35治疗青春期功血的疗效、不良反应、治疗特点等.方法收集2012年1月至2014年11月本院妇科收治的青春期功血患者122例,分为观察组和对照组.观察组使用达英-35进行治疗,对照组使用补佳乐+安宫黄体酮序贯治疗,观察两组治疗效果.结果观察组急性期止血效果优于对照组(P<0.01),差异有极显著性意义.观察组阴道流血减少时间和阴道流血停止时间均短于对照组,差异有显著性意义(P<0.05).两组患者治疗后的月经恢复情况比较,观察组优于对照组(P<0.05),差异有显著性意义.在不良反应的观察中,观察组的不良反应发生率为3.3%,对照组不良反应发生率为22.95%,观察组低于对照组(P<0.05),差异有显著性意义.结论本研究观察达英-35治疗青春期功血的临床疗效,得出达英-35在急性期的止血效果优于补佳乐,且达英-35止血起效时间快、不良反应少,观察随访发现其调经作用较补佳乐+安宫黄体酮序贯疗法更稳定.
【总页数】3页(P42-44)
【作者】朱莉
【作者单位】广东省惠州市第一妇幼保健院 516001
【正文语种】中文
【相关文献】
1.达英35治疗围绝经期功血50例疗效观察 [J], 张小琴
2.达英35联合2%米诺地尔溶液治疗女性型脱发疗效观察 [J], 储小燕;刘艳;富志良;芦桂青;康莉;毕志刚
3.参芪二仙片配合达英35治疗多囊卵巢综合征的临床疗效观察 [J], 臧晓霞
4.达英35联合二甲双胍在多囊卵巢治疗中的疗效观察 [J], 朱翠莲
5.肥胖型多囊卵巢综合症口服达英35联合二甲双胍治疗的疗效观察 [J], 杨六计;余海丽
因版权原因,仅展示原文概要,查看原文内容请购买。